Stocks and Investing Stocks and Investing
Tue, February 27, 2024
Mon, February 26, 2024

Terence Flynn Maintained (CCCC) at Hold with Increased Target to $8 on, Feb 26th, 2024


Published on 2024-10-28 09:13:09 - WOPRAI, Terence Flynn
  Print publication without navigation


Terence Flynn of Morgan Stanley, Maintained "C4 Therapeutics, Inc." (CCCC) at Hold with Increased Target from $1 to $8 on, Feb 26th, 2024.

Terence has made no other calls on CCCC in the last 4 months.



There are 4 other peers that have a rating on CCCC. Out of the 4 peers that are also analyzing CCCC, 1 agrees with Terence's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eric Joseph of "JP Morgan" Upgraded from Sell to Hold and Held Target at $6 on, Monday, January 29th, 2024


These are the ratings of the 3 analyists that currently disagree with Terence


  • Bradley Canino of "Stifel" Reiterated at Strong Buy with Increased Target to $13 on, Friday, February 23rd, 2024
  • Etzer Darout of "BMO Capital" Maintained at Buy with Decreased Target to $16 on, Friday, November 3rd, 2023
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $7 on, Thursday, November 2nd, 2023
Contributing Sources